Exact Mass: 281.017
Exact Mass Matches: 281.017
Found 245 metabolites which its exact mass value is equals to given mass value 281.017,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Flufenamic acid
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AG - Fenamates C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor CONFIDENCE standard compound; EAWAG_UCHEM_ID 3021 D000893 - Anti-Inflammatory Agents Flufenamic acid is a non-steroidal anti-inflammatory agent, inhibits cyclooxygenase (COX), activates AMPK, and also modulates ion channels, blocking chloride channels and L-type Ca2+ channels, modulating non-selective cation channels (NSC), activating K+ channels. Flufenamic acid binds to the central pocket of TEAD2 YBD and inhibits both TEAD function and TEAD-YAP-dependent processes, such as cell migration and proliferation.
Ajocysteine
Ajocysteine is found in onion-family vegetables. Ajocysteine is a constituent of garlic (Allium sativum). Constituent of garlic (Allium sativum). Ajocysteine is found in garlic and onion-family vegetables.
2-Chloro-N-(2-chloro-4-methylpyridin-3-yl)nicotinamide
Propanamide, 2-hydroxy-2-methyl-N-(3,4,5-trichlorophenyl)-
N-Acetyl-3-(3-chloro-4-fluoroanilino)-2-cyanoacrylamide
2-[4-(5-Methyl-3-phenylisoxazol-4-yl)-1,3-thiazol-2-yl]acetonitrile
Kathon 930
CONFIDENCE standard compound; EAWAG_UCHEM_ID 344
Iodopropynyl butylcarbamate
CONFIDENCE standard compound; INTERNAL_ID 2868 CONFIDENCE standard compound; INTERNAL_ID 8804 CONFIDENCE standard compound; INTERNAL_ID 8211 CONFIDENCE standard compound; INTERNAL_ID 4184
DCOIT
CONFIDENCE standard compound; INTERNAL_ID 2875 CONFIDENCE standard compound; INTERNAL_ID 8834
PRZ_M282
CONFIDENCE Transformation product, tentative ID (Level 2b); INTERNAL_ID 2001
Prochloraz BTS40348
CONFIDENCE standard compound; INTERNAL_ID 2647
flufenamic acid
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AG - Fenamates C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5428; ORIGINAL_PRECURSOR_SCAN_NO 5423 CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5418; ORIGINAL_PRECURSOR_SCAN_NO 5416 CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5457; ORIGINAL_PRECURSOR_SCAN_NO 5455 CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5442; ORIGINAL_PRECURSOR_SCAN_NO 5441 CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5524; ORIGINAL_PRECURSOR_SCAN_NO 5519 CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5447; ORIGINAL_PRECURSOR_SCAN_NO 5445 CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9133; ORIGINAL_PRECURSOR_SCAN_NO 9128 CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9153; ORIGINAL_PRECURSOR_SCAN_NO 9148 CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9175; ORIGINAL_PRECURSOR_SCAN_NO 9171 CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9182; ORIGINAL_PRECURSOR_SCAN_NO 9178 CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9162; ORIGINAL_PRECURSOR_SCAN_NO 9160 CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9196; ORIGINAL_PRECURSOR_SCAN_NO 9192 Flufenamic acid is a non-steroidal anti-inflammatory agent, inhibits cyclooxygenase (COX), activates AMPK, and also modulates ion channels, blocking chloride channels and L-type Ca2+ channels, modulating non-selective cation channels (NSC), activating K+ channels. Flufenamic acid binds to the central pocket of TEAD2 YBD and inhibits both TEAD function and TEAD-YAP-dependent processes, such as cell migration and proliferation.
1-cyclopropyl-6,7-difluoro-1,4-dihydro-8-hydroxy-4-oxo-3-Quinoline-3-carboxylic acid
6-Bromo-4-hydroxy-8-methylquinoline-3-carboxylic acid
5-Thiazolecarboxylicacid,2-(2-chlorophenyl)-4-methyl-,ethylester
7-Chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
N-(2-aminoethyl)-2-nitrobenzenesulfonamide,hydrochloride
1-(4-BROMO-1H-PYRROL-2-YL)-2,2,2-TRICHLORO-1-ETHANONE
2-(Methoxycarbonyl)aminophenylaminothioxomethyl-carbamic acid methyl ester
2-nitro-4-(trifluoromethyl)phenylthioglycolic acid
4-Thiazolidinone,5-[(3,4-dimethoxyphenyl)methylene]-2-thioxo-
guanfacine hydrochloride
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Guanfacine hydrochloride is an orally active noradrenergic α2A agonist and has high selective for the α2A receptor subtype. Guanfacine has effects in producing hypotension and sedation. Guanfacine can be used for the research of a variety of prefrontal cortex (PFC) cognitive disorders, including tourette's syndrome and attention deficit hyperactivity disorder (ADHD)[1][2][3].
[4-(chloromethyl)-2-oxo-2H-1-benzopyran-7-yl]-carbamic acid ethyl ester
2-CHLORO-1-[1-(4-CHLOROPHENYL)-2,5-DIMETHYL-1H-PYRROL-3-YL]-1-ETHANONE
ethyl 2-amino-4-(2-chlorophenyl)thiophene-3-carboxylate
2-aza-2-benzyl-7-bromo-6-hydroxy-2-bicyclo(2.2.1)heptane
4-(2-N-MALEIMIDO)METHYL BENZOHYDRAZIDE HYDROCHLORIDE
METHYL 3-AMINO-5-FLUORO-[1,1-BIPHENYL]-3-CARBOXYLATE HYDROCHLORIDE
METHYL 3-AMINO-3-FLUORO-[1,1-BIPHENYL]-4-CARBOXYLATE HYDROCHLORIDE
METHYL 3-AMINO-4-FLUORO-[1,1-BIPHENYL]-3-CARBOXYLATE HYDROCHLORIDE
D-TarB-NO2,2-(3-Nitrophenyl)-1,3,2-dioxaborolane-4S,5S-dicarboxylic acid
2-(1-(4-Bromophenyl)-1H-1,2,3-triazol-4-yl)propan-2-ol
B-HT 920
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists Talipexole dihydrochloride (B-HT 920 dihydrochloride) is a dopamine D2 receptor agonist, α2-adrenoceptor agonist and 5-HT3 receptor antagonist, which displays antiParkinsonian activity.
(1S,2R,5R)-5-(4-CHLORO-1H-IMIDAZO[4,5-C]PYRIDIN-1-YL)-3-(HYDROXYMETHYL)CYCLOPENT-3-ENE-1,2-DIOL
1H-Indole,1-methyl-3-[5-(2-thienyl)-1,3,4-oxadiazol-2-yl]-(9CI)
2-amino-4-(4-chloro-phenyl)-thiophene-3-carboxylic acid ethyl ester
ETHYL-5-CHLORO-1,2-DIHYDRO-4-HYDROXY-1-METHYL-2-OXO-3-QUINOLINE CARBOXYLATE
Methyl 6-bromo-4-oxo-1,4-dihydroquinoline-2-carboxylate
1-(5-(2,2,2-TRICHLOROACETYL)-1H-PYRROL-3-YL)BUTAN-1-ONE
2-AMINO-4-(3-CHLOROPHENYL)-5-METHYL-THIOPHENE-3-CARBOXYLIC ACID METHYL ESTER
1-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]piperidine-4-carboxylic acid
2-(6-FLUOROPYRIDIN-3-YL)-6-(TRIFLUOROMETHYL)-1H-BENZO[D]IMIDAZOLE
5-(1-Chloro-2-methylpropan-2-yl)-3-(4-nitrophenyl)-1,2,4-oxadiazole
5-(1-Chloro-2-methylpropan-2-yl)-3-(3-nitrophenyl)-1,2,4-oxadiazole
6-Isoquinolinecarboxylic acid, 5,7-dichloro-1,2,3,4-tetrahydro-, hydrochloride
4-[(4-chloro-2-nitrophenyl)azo]-2,4-dihydro-5-methyl-3H-pyrazol-3-one
1-[4-(3-bromothiophen-2-yl)phenyl]-N-methylmethanamine
5-Bromo-3-isopentyl-2-methyl-3H-imidazo[4,5-b]pyridine
5-BROMO-2-(TETRAHYDRO-2H-PYRAN-4-YLOXY)BENZONITRILE
5,7-dichloro-2-(3-fluorophenyl)pyrazolo[1,5-a]pyrimidine
5,7-dichloro-2-(4-fluorophenyl)pyrazolo[1,5-a]pyrimidine
2-[3-chloro-4-(trifluoromethyl)phenyl]benzonitrile
6-Bromo-2,2-spirocycloheptane-2,3-dihydro-1H-imidazo[4,5-b]pyridine
3-((2,4-Dichlorobenzyl)oxy)pyrrolidine hydrochloride
2-(4-Aminophenyl)imidazo[2,1-b][1,3]benzothiazol-7-ol
5-(1,1,1,3,3,3-Hexafluoro-2-hydroxy-2-propanyl)-4,5-dihydro-1,2-o xazole-3-carboxylic acid
1-(4-trifluoromethyl)phenylbiguanide hydrochloride
Ethyl 2-(4-chlorophenyl)-4-methyl-1,3-thiazole-5-carboxylate
(4R,5R)-2-(3-nitrophenyl)-1,3,2-dioxaborolane-4,5-dicarboxylic acid
[5-(4-BROMO-PHENYL)-4H-[1,2,4]TRIAZOL-3-YL]-ACETIC ACID
4-Thiazolidinone,5-[(3-ethoxy-4-hydroxyphenyl)methylene]-2-thioxo-
2-CHLORO-5,6,7-TRIMETHOXY-QUINOLINE-3-CARBALDEHYDE
SPIRO[3H-INDOLE-3,4-[4H]PYRAN]-2(1H)-ONE,5-BROMO-2,3,5,6-TETRAHYDRO-
5-(4-Bromo-Phenyl)-3-Methyl-Isoxazole-4-Carboxylic Acid
7-(Acetylamino)-4-hydroxy-2-naphthalenesulfonic acid
N-((5-bromofuran-2-yl)methyl)-2-(methylsulfonyl)ethanamine
ETHYL 5-HYDROXY-2-(METHYLTHIO)-7-OXO-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBOXYLATE
Methyl 5-(4-bromophenyl)-1,2-oxazole-3-carboxylate
Cloral betaine
C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic
6-fluoro-3-[4-(trifluoromethyl)phenyl]-1,2-benzoxazole
2-(5-amino-6-oxo-2-phenylpyrimidin-1-yl)acetic acid,hydrochloride
2-(4-Bromo-1H-pyrrolo[2,3-b]pyridin-2-yl)-N,N-dimethylacetamide
2-[2-(AMINOMETHYL)PHENYLTHIO]BENZYL ALCOHOL HYDROCHLORIDE
(S)-2-(3-BROMOPHENYL)-4-(TERT-BUTYL)-4,5-DIHYDROOXAZOLE
2-(1,4-Benzodioxan-2-yl)thiazole-4-carbonyl chloride
(S)-2-(2-Bromophenyl)-4-(tert-butyl)-4,5-dihydrooxazole
2-AMINO-4-(4-CHLORO-PHENYL)-5-METHYL-THIOPHENE-3-CARBOXYLIC ACID METHYL ESTER
N-(2,4-Dinitrophenyl)-L-proline
The L-stereoisomer of N-(2,4-dinitrophenyl)proline, a proline derivative having a 2,4-dinitrophenyl substituent on nitrogen.
6-BROMO-5-METHOXY-1,2-DIMETHYL-1H-INDOLE-3-CARBALDEHYDE
2-(4-((2,4-Dioxothiazolidin-5-yl)methyl)phenoxy)acetic acid
4-ALLYL-5-[(4-CHLOROPHENOXY)METHYL]-4H-1,2,4-TRIAZOLE-3-THIOL
2-Furanmethanaminium,N,N,N,5-tetramethyl-, iodide (1:1)
4-ISOXAZOLECARBOXYLIC ACID, 3-(4-BROMOPHENYL)-5-METHYL-
5-(4-bromo-2-methylphenyl)-1,3-oxazole-4-carboxylic acid
5-(2-methoxy-4-nitrophenyl)furan-2-carbonyl chloride
1-CYCLOPROPYL-6,7-DIFLUORO-8-HYDROXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID
methyl 7-bromo-2,3-dihydro-1h-1-benzazepine-4-carboxylate
Proflavine dihydrochloride
C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent
N-[(2-chloropyridin-3-yl)carbamothioyl]furan-2-carboxamide
Methyl 3-[2-(2-thienyl)acetamido]thiophene-2-carboxylate
2-chloro-N-(2-chloro-5-methylsulfonylphenyl)acetamide
3-(2-Hydroxyethylsulfanyl)-6,6-dimethyl-4-oxo-5,7-dihydro-2-benzothiophene-1-carbonitrile
4-bromo-N-(3,4-dihydro-2H-pyrrol-5-yl)benzohydrazide
N-[5-(2-methylpropyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide
N-(4-nitro-1,2,5-oxadiazol-3-yl)-2-pyridin-2-ylsulfanylacetamide
Pseudobaptigenin(1-)
A flavonoid oxoanion that is the conjugate base of pseudobaptigenin, obtained by deprotonation of the hydroxy group. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
